IL133056A0 - A polypeptide containing an immunogenic portion of a m tuberculosis antigen a variant thereof pharmaceutical compositions vaccines and kits containing same - Google Patents

A polypeptide containing an immunogenic portion of a m tuberculosis antigen a variant thereof pharmaceutical compositions vaccines and kits containing same

Info

Publication number
IL133056A0
IL133056A0 IL13305698A IL13305698A IL133056A0 IL 133056 A0 IL133056 A0 IL 133056A0 IL 13305698 A IL13305698 A IL 13305698A IL 13305698 A IL13305698 A IL 13305698A IL 133056 A0 IL133056 A0 IL 133056A0
Authority
IL
Israel
Prior art keywords
sequences
polypeptide
antigen
dna
variant
Prior art date
Application number
IL13305698A
Other languages
English (en)
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of IL133056A0 publication Critical patent/IL133056A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL13305698A 1997-05-20 1998-05-20 A polypeptide containing an immunogenic portion of a m tuberculosis antigen a variant thereof pharmaceutical compositions vaccines and kits containing same IL133056A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85938197A 1997-05-20 1997-05-20
US09/073,010 US6613881B1 (en) 1997-05-20 1998-05-05 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
PCT/US1998/010407 WO1998053075A2 (en) 1997-05-20 1998-05-20 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use

Publications (1)

Publication Number Publication Date
IL133056A0 true IL133056A0 (en) 2001-03-19

Family

ID=26754016

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13305698A IL133056A0 (en) 1997-05-20 1998-05-20 A polypeptide containing an immunogenic portion of a m tuberculosis antigen a variant thereof pharmaceutical compositions vaccines and kits containing same
IL133056A IL133056A (en) 1997-05-20 1999-11-19 Polypeptide containing an immunogenic portion of an m. tuberculosis antigen, a variant thereof and pharmaceutical compositions containing same

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL133056A IL133056A (en) 1997-05-20 1999-11-19 Polypeptide containing an immunogenic portion of an m. tuberculosis antigen, a variant thereof and pharmaceutical compositions containing same

Country Status (20)

Country Link
US (1) US6613881B1 (xx)
EP (4) EP1012293B1 (xx)
JP (4) JP4162155B2 (xx)
KR (4) KR100909640B1 (xx)
AT (1) ATE420180T1 (xx)
AU (1) AU742751B2 (xx)
BR (1) BR9809445A (xx)
CA (2) CA2783134A1 (xx)
CZ (2) CZ300866B6 (xx)
DE (1) DE69840449D1 (xx)
DK (1) DK1012293T3 (xx)
ES (1) ES2321039T3 (xx)
HU (1) HU226520B1 (xx)
IL (2) IL133056A0 (xx)
NO (4) NO324880B1 (xx)
NZ (1) NZ501310A (xx)
PL (1) PL191121B1 (xx)
PT (1) PT1012293E (xx)
TR (1) TR200000115T2 (xx)
WO (1) WO1998053075A2 (xx)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6991797B2 (en) 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US6290969B1 (en) * 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6592877B1 (en) * 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US7037510B2 (en) 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
US7087713B2 (en) * 2000-02-25 2006-08-08 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
EP0986572B2 (en) 1997-06-06 2007-06-13 Dynavax Technologies Corporation Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
EP1029053A1 (en) * 1997-11-10 2000-08-23 Statens Seruminstitut Nucleic acid fragments and polypeptide fragments derived from mycobacterium tuberculosis
MXPA01004469A (es) * 1998-11-04 2002-08-30 Isis Innovation Prueba de diagnostico para la tuberculosis.
US20030027774A1 (en) * 1999-03-18 2003-02-06 Ronald C. Hendrickson Tuberculosis antigens and methods of use therefor
US8143386B2 (en) * 1999-04-07 2012-03-27 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
CA2378763A1 (en) 1999-07-13 2001-01-18 Statens Serum Institut Tuberculosis vaccine and diagnostics based on the mycobacterium tuberculosis esat-6 gene family
JP2003510370A (ja) 1999-10-07 2003-03-18 コリクサ コーポレイション Mycobacteriumtuberculosisの融合タンパク質
US6316205B1 (en) 2000-01-28 2001-11-13 Genelabs Diagnostics Pte Ltd. Assay devices and methods of analyte detection
EP1278769A2 (en) * 2000-04-19 2003-01-29 Statens Serum Institut Tuberculosis antigens and methods of use thereof
AU6867801A (en) * 2000-06-20 2002-01-02 Corixa Corp Fusion proteins of mycobacterium tuberculosis
WO2003070187A2 (en) * 2002-02-15 2003-08-28 Corixa Corporation Fusion proteins of mycobacterium tuberculosis
US7482116B2 (en) 2002-06-07 2009-01-27 Dna Genotek Inc. Compositions and methods for obtaining nucleic acids from sputum
US20050164168A1 (en) * 2003-03-28 2005-07-28 Cullum Malford E. Method for the rapid diagnosis of infectious disease by detection and quantitation of microorganism induced cytokines
US8475735B2 (en) * 2004-11-01 2013-07-02 Uma Mahesh Babu Disposable immunodiagnostic test system
KR101255870B1 (ko) 2004-11-16 2013-04-17 아에라스 글로벌 티비 백신 파운데이션 재조합 바이러스 벡터를 포함하는 다가 백신
EP1904848A2 (en) 2005-04-29 2008-04-02 Fusion Antibodies Limited Assays for diagnosis of tuberculosis and uses thereof
US7968694B2 (en) 2005-07-01 2011-06-28 Forsyth Dental Infirmary For Children Tuberculosis antigen detection assays and vaccines
US20070081944A1 (en) * 2005-09-30 2007-04-12 Reed Steven G Iontophoresis apparatus and method for the diagnosis of tuberculosis
US7842299B2 (en) 2006-03-14 2010-11-30 Oregon Health & Science University Methods for producing an immune response to tuberculosis
BRPI0916703A2 (pt) * 2008-07-25 2019-12-24 Glaxo Group Ltd usos de um polipeptídeo, e de um polinucleotídeo, e, composição
PL2315834T3 (pl) 2008-07-25 2018-12-31 Glaxosmithkline Biologicals S.A. Białko rv2386c związane z gruźlicą, jego kompozycje i zastosowania
HRP20171694T1 (hr) 2008-07-25 2017-12-15 Glaxosmithkline Biologicals S.A. Novi pripravci i postupci
KR20120129927A (ko) 2010-01-27 2012-11-28 글락소 그룹 리미티드 변형된 투베르쿨로시스 항원
GB201012072D0 (en) 2010-07-19 2010-09-01 Sec Dep For Environment Food A Diagnostic reagents
JP6193850B2 (ja) 2011-06-19 2017-09-06 アボゲン,インコーポレイティド サンプル収集のためのデバイス、溶液及び方法
US12038434B2 (en) 2015-02-09 2024-07-16 DNA Genotek, Inc. Devices, solutions and methods for sample collection related applications, analysis and diagnosis

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4751180A (en) 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US4689397A (en) 1985-08-12 1987-08-25 Scripps Clinic And Research Foundation Synthetic polypeptides for detecting mycobacterial infections
US4935233A (en) 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
US4879213A (en) 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
US4976958A (en) * 1987-02-26 1990-12-11 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides
US4952395A (en) 1987-02-26 1990-08-28 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides
US6037135A (en) * 1992-08-07 2000-03-14 Epimmune Inc. Methods for making HLA binding peptides and their uses
US5330754A (en) 1992-06-29 1994-07-19 Archana Kapoor Membrane-associated immunogens of mycobacteria
JPH09510866A (ja) * 1993-12-23 1997-11-04 アグリサーチ ニュージーランド パストラル アグリカルチャー リサーチ インスティテュート,リミテッド ミコバクテリア毒力因子およびその同定のための方法
AU706367B2 (en) * 1995-03-13 1999-06-17 Astra Aktiebolag New DNA molecules
MX9801638A (es) 1995-09-01 1998-05-31 Corixa Corp Compuestos y metodos para inmunoterapia y diagnostico de tuberculosis.
US6290969B1 (en) * 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
ATE530671T1 (de) 1995-09-01 2011-11-15 Corixa Corp Verbindungen und verfahren zur diagnose von tuberkulose
CZ126699A3 (cs) * 1996-10-11 1999-09-15 Corixa Corporation Polypeptid obsahující antigenní část rozpustného antigenu M. tuberculosis nebo variantu uvedeného antigenu, molekula DNA kódující tento polypeptid, expresivní vektor, hostitelská buňka, způsoby diagnostiky infekce M. tuberculosis a diagnostické kity

Also Published As

Publication number Publication date
WO1998053075A3 (en) 1999-04-01
WO1998053075A2 (en) 1998-11-26
NO20075900L (no) 2000-01-18
HUP0003402A3 (en) 2001-03-28
EP2172551A2 (en) 2010-04-07
CZ303194B6 (cs) 2012-05-23
US6613881B1 (en) 2003-09-02
KR100652513B1 (ko) 2006-12-01
PT1012293E (pt) 2009-04-08
CA2290774A1 (en) 1998-11-26
KR20080036663A (ko) 2008-04-28
NO995689D0 (no) 1999-11-19
JP4764445B2 (ja) 2011-09-07
NO995689L (no) 2000-01-18
JP2008283961A (ja) 2008-11-27
JP2002514084A (ja) 2002-05-14
DK1012293T3 (da) 2009-05-04
DE69840449D1 (de) 2009-02-26
NO20075901L (no) 2000-01-18
JP2008253260A (ja) 2008-10-23
ES2321039T3 (es) 2009-06-01
KR100893118B1 (ko) 2009-04-14
PL191121B1 (pl) 2006-03-31
NO20075902L (no) 2000-01-18
KR20070026886A (ko) 2007-03-08
JP4759010B2 (ja) 2011-08-31
AU7690798A (en) 1998-12-11
CZ410099A3 (cs) 2000-05-17
JP2008245644A (ja) 2008-10-16
TR200000115T2 (tr) 2000-11-21
CZ300866B6 (cs) 2009-08-26
NO324880B1 (no) 2007-12-27
BR9809445A (pt) 2000-06-13
CA2783134A1 (en) 1998-11-26
KR100924475B1 (ko) 2009-11-03
EP2172551A3 (en) 2010-11-10
KR20060066139A (ko) 2006-06-15
NZ501310A (en) 2001-09-28
KR20010012812A (ko) 2001-02-26
KR100909640B1 (ko) 2009-07-27
EP1012293B1 (en) 2009-01-07
IL133056A (en) 2010-11-30
HU226520B1 (en) 2009-03-30
EP1012293A2 (en) 2000-06-28
PL337330A1 (en) 2000-08-14
JP4162155B2 (ja) 2008-10-08
EP2248900A1 (en) 2010-11-10
HUP0003402A2 (hu) 2000-12-28
EP2270170A1 (en) 2011-01-05
EP2270170B1 (en) 2013-11-06
JP4759011B2 (ja) 2011-08-31
AU742751B2 (en) 2002-01-10
ATE420180T1 (de) 2009-01-15
EP2248900B1 (en) 2012-07-18

Similar Documents

Publication Publication Date Title
IL133056A0 (en) A polypeptide containing an immunogenic portion of a m tuberculosis antigen a variant thereof pharmaceutical compositions vaccines and kits containing same
EP1806402A3 (en) CTLA4/CD28 ligands and uses therefor
NZ502391A (en) Mammalian cytokine: interleukin-B30 and related reagents
CA2263889A1 (en) P-selectin ligand proteins
EP0784059A4 (en) ANTIGENIC POLYPEPTIDE OF CHLAMYDIA PNEUMONIAE
AU2759895A (en) Recombinant allergen, fragments thereof, corresponding recombinant dna molecules, vectors and hosts containing the dna molecules, diagnostic and therapeutic uses of said allergens and fragments
DE3686579D1 (en) Prokaryotisches expressionssystem.
AU5776799A (en) Modified hcv peptide vaccines
EP0805204A3 (de) Nebenhoden-spezifisches Rezeptorprotein und dessen Verwendung
EP1277837A3 (de) Epididymis-spezifische DNA-Sequenzen und deren Verwendung
SE9704141D0 (sv) New protein and nucleotide sequence, encoding said protein
KR930701603A (ko) 재조합 47 및 31 킬로달톤 코코아 단백질 및 그의 전구체
WO1995008628A3 (en) Nucleic acids encoding merosin, merosin fragments and uses thereof
WO2003097814A3 (en) Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins
CA2315282A1 (en) Single-chain polypeptides comprising troponin i and troponin c
WO1990007000A3 (en) Nucleotides encoding human b1, 4-galactosyltransferase and uses thereof
PE20010239A1 (es) Gen derivado de lawsonia y polipeptidos, peptidos y proteinas de hemolisina relacionados y sus usos
EP0897984A3 (en) D-Sorbitol dehydrogenase gene
AU2001251410A1 (en) 12303, a novel human twik molecule and uses thereof
DE60033583D1 (de) Eine mycobacterium tuberculosis kodierende sequenz zur expression von heterologen proteinen
WO1999043834A3 (en) P-selectin ligand protein, including tetrameric fusion proteins
WO1997031104A3 (en) Candida albicans profilin gene
CA2323506A1 (en) Mammalian blood loss-induced gene, kd312
WO2001046412A3 (de) Interaktionsprotein für stat transkriptionsfaktor
NZ511303A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same with homology to Hep27 protein